Ozette Technologies is a biotechnology startup founded in 2021, with a powerful slogan - "Unlocking the power of the immune system to treat and prevent disease." The company is focused on enabling the next generation of breakthroughs in treating human disease. With its headquarters in the United States, Ozette Technologies secured a significant Series A investment of $26.00M on 28 July 2022. Noteworthy investors in this round include Madrona, M12, Alexandria Venture Investments, OCV Partners, Cercano Management, and Duke University. Ozette Technologies' innovative approach to leveraging the immune system for disease treatment and prevention positions it as a compelling player in the biotechnology sector with promising potential for impactful advancements.
No recent news or press coverage available for Ozette.